Infection in organ-transplant recipients
JA Fishman, RH Rubin - New England Journal of Medicine, 1998 - Mass Medical Soc
A primary goal in organ transplantation is the prevention or effective treatment of infection,
the most common life-threatening complication of long-term immunosuppressive therapy …
the most common life-threatening complication of long-term immunosuppressive therapy …
[HTML][HTML] Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system
C Steininger - Clinical Microbiology and Infection, 2007 - Elsevier
Cytomegalovirus (CMV) infection is one of the most important infectious complications of
solid-organ transplantation, and is also responsible for serious, life-threatening diseases in …
solid-organ transplantation, and is also responsible for serious, life-threatening diseases in …
Overview of the diagnosis of cytomegalovirus infection
SA Ross, Z Novak, S Pati… - Infectious Disorders-Drug …, 2011 - ingentaconnect.com
Cytomegalovirus (CMV) is recognized as the most common congenital viral infection in
humans and an important cause of morbidity and mortality in immunocompromised hosts …
humans and an important cause of morbidity and mortality in immunocompromised hosts …
[图书][B] Hepatology Principles and Practice: History· Morphology Biochemistry· Diagnostics Clinic· Therapy
E Kuntz - 2006 - Springer
Metabolic processes utilize a variety of differing and contrasting biochemical routes to
enable synthesis of degradation and activation or deactivation of substances; in addition …
enable synthesis of degradation and activation or deactivation of substances; in addition …
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients
MD Pescovitz, J Rabkin, RM Merion… - Antimicrobial agents …, 2000 - Am Soc Microbiol
The pharmacokinetics of an orally administered valine ester of ganciclovir (GCV),
valganciclovir (VGC), were studied. These were compared to the pharmacokinetics of oral …
valganciclovir (VGC), were studied. These were compared to the pharmacokinetics of oral …
Invasive aspergillosis in liver transplant recipients in the 1990s
N Singh, PM Arnow, A Bonham, E Dominguez… - …, 1997 - journals.lww.com
Invasive aspergillosis occurred in 26 liver transplant recipients since 1990 at five liver
transplant centers. The median time to onset was 17 days after transplantation. Twenty …
transplant centers. The median time to onset was 17 days after transplantation. Twenty …
Mechanisms of human cytomegalovirus (HCMV)(re) activation and its impact on organ transplant patients
P Reinke, S Prösch, F Kern… - Transplant infectious …, 1999 - Wiley Online Library
Human cytomegalovirus (HCMV) infection plays an important role in transplant patients. Its
impact is both direct and indirect. This review focuses on new aspects of HCMV (re) …
impact is both direct and indirect. This review focuses on new aspects of HCMV (re) …
Ischemic cholangiopathy
P Deltenre, DC Valla - Journal of hepatology, 2006 - journal-of-hepatology.eu
Ischemic cholangiopathy can be defined as a focal or extensive damage to the bile ducts
due to impaired blood supply [1]. This entity may be observed in various circumstances …
due to impaired blood supply [1]. This entity may be observed in various circumstances …
Quantification of human cytomegalovirus DNA by real-time PCR
E Gault, Y Michel, A Dehée, C Belabani… - Journal of clinical …, 2001 - Am Soc Microbiol
ABSTRACT A quantitative real-time PCR assay was developed to measure human
cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes (PBLs). The HCMV DNA …
cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes (PBLs). The HCMV DNA …
Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients
N Singh - Clinical infectious diseases, 2001 - academic.oup.com
Whether preemptive therapy or universal prophylaxis with ganciclovir is the optimal
approach against cytomegalovirus (CMV) remains unresolved. Controversy abounds with …
approach against cytomegalovirus (CMV) remains unresolved. Controversy abounds with …